stockrowInterCure Ltd. (INCR) vs SCYNEXIS, Inc. (SCYX)
- InterCure Ltd. INCR 3.25 −1.52%
- SCYNEXIS, Inc. SCYX 3.47 +5.15%
InterCure Ltd. and SCYNEXIS, Inc. are both Drug Manufacturers Specialty & Generic companies. InterCure Ltd. is the larger, with a market value of $39.1M against $32.8M — 1.2× the size. SCYNEXIS, Inc. has negative trailing earnings, so its P/E is not meaningful; InterCure Ltd. trades at 6.2×. SCYNEXIS, Inc. grew revenue faster over the last twelve months: 682.5% against 16.2%. InterCure Ltd. has the higher net margin (4.88% vs −49.7%) and the higher return on invested capital (0.00% vs −110.7%). Across the 18 metrics below, InterCure Ltd. leads on 11 and SCYNEXIS, Inc. on 7.
Valuation
Profitability
| Metric | INCR | SCYX | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 32.74% | 100.00% | 53.51% |
| Operating margin | 0.00% | (109.90%) | 0.00% |
| Net margin | 4.88% | (49.74%) | (2.45%) |
| Free cash flow margin | 0.00% | (64.67%) | 0.00% |
| Return on equity | 0.00% | (18.38%) | (0.80%) |
| Return on assets | 0.00% | (15.09%) | (1.67%) |
| Return on invested capital | 0.00% | (110.72%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack